These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32113215)

  • 1. Pharmaceutical industry payments to leaders of professional medical associations in Australia: Focus on cardiovascular disease and diabetes.
    Karanges EA; Ting N; Parker L; Fabbri A; Bero L
    Aust J Gen Pract; 2020 Mar; 49(3):151-154. PubMed ID: 32113215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Financial ties between leaders of influential US professional medical associations and industry: cross sectional study.
    Moynihan R; Albarqouni L; Nangla C; Dunn AG; Lexchin J; Bero L
    BMJ; 2020 May; 369():m1505. PubMed ID: 32461201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical industry payments and assisted reproduction in Australia: a retrospective observational study.
    Karanges EA; Nangla C; Parker L; Fabbri A; Farquhar C; Bero L
    BMJ Open; 2021 Aug; 11(9):e049710. PubMed ID: 34465582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pain Medicine Ethics Forum: Key Opinion Leaders with Industry Conflicts of Interest Should Be Able to Hold Leadership Positions in Professional Medical Associations.
    Wallace MS
    Pain Med; 2016 Feb; 17(2):218. PubMed ID: 26814302
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaceutical Industry Payments to Professional Medical Societies in Japan.
    Murayama A; Higuchi K; Senoo Y
    J Gen Intern Med; 2024 Jun; 39(8):1534-1535. PubMed ID: 38519746
    [No Abstract]   [Full Text] [Related]  

  • 6. Industry Payment to Vascular Neurologists: A 6-Year Analysis of the Open Payments Program From 2013 Through 2018.
    Nalleballe K; Sheng S; Li C; Mahashabde R; Annapureddy AR; Mudassar K; Pothineni K; Veerapaneni P; Harada Y; Chilkulwar A; Ranabothu S; Brown A; Kapoor N; Onteddu S
    Stroke; 2020 Apr; 51(4):1339-1343. PubMed ID: 32078482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Financial conflicts of interest between pharmaceutical companies and executive board members of internal medicine subspecialty societies in Japan between 2016 and 2020.
    Murayama A; Saito H; Tanimoto T; Ozaki A
    J Eval Clin Pract; 2023 Sep; 29(6):883-886. PubMed ID: 37283452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical company payments to authors of the Japanese guidelines for the management of hypertension.
    Senoo Y; Saito H; Ozaki A; Sawano T; Shimada Y; Yamamoto K; Suzuki Y; Tanimoto T
    Medicine (Baltimore); 2021 Mar; 100(12):e24816. PubMed ID: 33761642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations.
    Kerridge I; Maguire J; Newby D; McNeill PM; Henry D; Hill S; Day R; Macdonald G; Stokes B; Henderson K
    Intern Med J; 2005 Apr; 35(4):206-10. PubMed ID: 15836497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia.
    Fabbri A; Grundy Q; Mintzes B; Swandari S; Moynihan R; Walkom E; Bero LA
    BMJ Open; 2017 Jun; 7(6):e016701. PubMed ID: 28667226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Professional Medical Associations and Divestiture from Industry: An Ethical Imperative for Pain Society Leadership.
    Rothman DJ
    Pain Med; 2016 Feb; 17(2):218-9. PubMed ID: 26814303
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaceutical Industry Payments to Medical Oncologists in the Netherlands: Trends and Patterns Provided by an Open-Access Transparency Data Set.
    Schnog JB; Samson MJ; Gersenbluth I; Duits AJ
    JCO Oncol Pract; 2024 Jun; 20(6):843-851. PubMed ID: 38354335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan.
    Saito H; Ozaki A; Sawano T; Shimada Y; Tanimoto T
    JAMA Netw Open; 2019 Apr; 2(4):e192834. PubMed ID: 31026027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Industry payments to Australian medical oncologists and clinical haematologists: a cross-sectional analysis of publicly available disclosures.
    Pokorny AMJ; Bero LA; Moynihan R; Mintzes BJ
    Intern Med J; 2021 Nov; 51(11):1816-1824. PubMed ID: 32744396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Industry Funding Among Leadership in Medical Oncology and Radiation Oncology in 2015.
    Yoo SK; Ahmed AA; Ileto J; Zaorsky NG; Deville C; Holliday EB; Wilson LD; Jagsi R; Thomas CR
    Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):280-285. PubMed ID: 28366578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the type and amount of spending disclosed by Australian pharmaceutical companies: an observational study.
    Parker L; Karanges EA; Bero L
    BMJ Open; 2019 Feb; 9(2):e024928. PubMed ID: 30782921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Payments From Pharmaceutical Companies to Authors Involved in the Valsartan Scandal in Japan.
    Sawano T; Ozaki A; Saito H; Shimada Y; Tanimoto T
    JAMA Netw Open; 2019 May; 2(5):e193817. PubMed ID: 31099864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Financial ties between authors of the clinical practice guidelines and pharmaceutical companies: an example from Japan.
    Saito H; Tani Y; Ozaki A; Sawano T; Shimada Y; Yamamoto K; Tanimoto T
    Clin Microbiol Infect; 2019 Nov; 25(11):1304-1306. PubMed ID: 31401175
    [No Abstract]   [Full Text] [Related]  

  • 19. Australian regulator insists on greater transparency of industry payments to doctors.
    Coopes A
    BMJ; 2014 Oct; 349():g6335. PubMed ID: 25331811
    [No Abstract]   [Full Text] [Related]  

  • 20. Dangerous liaisons: doctors-in-training and the pharmaceutical industry.
    Pokorny AM; Gittins CB
    Intern Med J; 2015 Oct; 45(10):1085-8. PubMed ID: 26429220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.